tiprankstipranks
Trending News
More News >
Abbott Laboratories (DE:ABL)
XETRA:ABL
Germany Market

Abbott Laboratories (ABL) Income Statement

Compare
16 Followers

Abbott Laboratories Income Statement

Last quarter (Q4 2025), Abbott Laboratories's total revenue was $11.46B, an increase of 4.42% from the same quarter last year. In Q4, Abbott Laboratories's net income was $1.78B. See Abbott Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 44.33B$ 41.95B$ 40.11B$ 43.65B$ 43.08B
Gross Profit
$ 24.61B$ 21.32B$ 20.04B$ 22.32B$ 23.21B
Operating Expenses
$ 16.59B$ 14.47B$ 13.60B$ 13.96B$ 14.01B
Depreciation and Amortization
$ 2.75B$ 3.22B$ 3.24B$ 3.27B$ 3.54B
EBITDA
$ 11.55B$ 10.83B$ 10.61B$ 11.89B$ 12.16B
Operating Income
$ 8.05B$ 6.83B$ 6.43B$ 8.36B$ 9.20B
Other Income/Expenses
$ 418.00M$ 188.00M$ 229.00M$ -56.00M$ -989.00M
Pretax Income
$ 8.47B$ 7.01B$ 6.66B$ 8.31B$ 8.21B
Net Income
$ 6.52B$ 13.40B$ 5.72B$ 6.93B$ 7.07B
Per Share Metrics
Basic EPS
$ 3.74$ 7.67$ 3.30$ 3.94$ 3.97
Diluted EPS
$ 3.72$ 7.64$ 3.27$ 3.91$ 3.94
Weighted Average Shares Outstanding
1.75B 1.73B 1.73B 1.75B 1.77B
Weighted Average Shares Outstanding (Diluted)
1.75B 1.75B 1.75B 1.76B 1.79B
Currency in USD

Abbott Laboratories Earnings and Revenue History